ArticleGenes & genomics2025
Hierarchical structural component model for pathway analysis of multinomial phenotypes.
Article in Genes & genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundMany statistical methods for pathway analysis have been used to identify novel pathways from biomarkers associated with a certain disease. However, most of these methods are based on single pathway analysis and do not consider multiple pathways simultaneously. To address this issue, a hierarchical structural component model (HisCoM) was developed, which takes into account all pathways at the same time, as well as takes into consideration the correlations among them. HisCoM has been successfully applied to the analysis of continuous, count, and binary phenotypes.
objectiveIn this study, our goal is to propose HisCoM-Categ by extending HisCoM for pathway analysis for both nominal or ordinal multinomial phenotypes, when the phenotypes have more than two possible unordered or ordered discrete categories.
methodsThe foundation of the proposed HisCoM-Categ is the multivariate extension of generalized linear models. Specifically, HisCoM-Categ accounts for the hierarchical structure of biomarkers and pathways, as well as the correlations that exist among pathways.
resultsThrough the simulation study, HisCoM-Categ was shown to have higher power compared to the other existing methods. In addition, HisCoM-Categ was illustrated with two different omics datasets, including metabolomic, and metagenomic datasets. HisCoM-Categ for ordinal multinomial phenotypes was illustrated by the metabolomic and metagenomic datasets. Those applications demonstrated that HisCoM-Categ successfully identified the well-known pathways that are associated with multinomial phenotypes.
conclusionsThe current study proposes a novel pathway analysis method HisCoM-Categ to identify pathways that have been associated with multinomial phenotypes.
Indexed as
Identifiers
40608216What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.